Form 4: United Therapeutics Director Richard Giltner Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Richard Giltner exercised stock options and sold shares of United Therapeutics Corp on November 5, 2024.
Summary
- On November 5, 2024, Richard Giltner, a director of United Therapeutics Corporation, executed stock options to acquire 10,000 shares of common stock at a price of $175.43 per share.
- Simultaneously, Giltner sold 8,571 shares at a weighted average price of $381.6065 and 1,429 shares at a weighted average price of $382.2762.
- Following these transactions, Giltner directly owns 17,420 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date stock options were granted. |
| 11/05/2024 | Date of stock option exercise and share sales. |
| 06/26/2025 | Expiration date of stock options. |
| 11/06/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.